Order Article Reprints

Maldonado S, Fuentes P, Bernabeu E, Bertera F, Opezzo J, Lagomarsino E, Lee HJ, Martínez Rodríguez F, Choi MR, Salgueiro MJ, et al. Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses. Pharmaceutics. 2025; 17(2):241. https://doi.org/10.3390/pharmaceutics17020241

Maldonado, Sofía, Pedro Fuentes, Ezequiel Bernabeu, Facundo Bertera, Javier Opezzo, Eduardo Lagomarsino, Hyun J. Lee, Fleming Martínez Rodríguez, Marcelo R. Choi, María Jimena Salgueiro, and et al. 2025. "Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses" Pharmaceutics 17, no. 2: 241. https://doi.org/10.3390/pharmaceutics17020241

Maldonado, S., Fuentes, P., Bernabeu, E., Bertera, F., Opezzo, J., Lagomarsino, E., Lee, H. J., Martínez Rodríguez, F., Choi, M. R., Salgueiro, M. J., Damonte, E. B., Höcht, C., Moretton, M. A., Sepúlveda, C. S., & Chiappetta, D. A. (2025). Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses. Pharmaceutics, 17(2), 241. https://doi.org/10.3390/pharmaceutics17020241